#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Macular telangiectasia Neurodegenerative disorder Plasma cell myeloma Epilepsy Bronchopulmonary dysplasia Encephalitis autoimmune Small intestine adenocarcinoma Plasma cell myeloma recurrent Adenocarcinoma gastric Netherton's syndrome Penile cancer Squamous cell carcinoma of the oral cavity Idiopathic inflammatory myopathy Giant cell tumour of tendon sheath Langerhans' cell histiocytosis More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Diagnostics Burkitt’s lymphoma – Treatment Proteus syndrome – Diagnostics Kearns-Sayre syndrome – Diagnostics Pemphigoid – Treatment IgA nephropathy – Trials in Disease Behcet’s syndrome – Basic Information Cystic fibrosis lung Hereditary optic atrophy Medulloblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    KETOROLAC TROMETAMOL NADOFARAGENE FIRADENOVEC Terbinafine Vosilasarm Varenicline Octocog Alfa AGALSIDASE BETA Cefazolin 2-DEOXY-D-GLUCOSE Nms-03305293 Avacopan Gabapentin Alendronic Acid Eltrombopag Iph5201 ANGIOTENSIN II Posenacaftor Insulin Human (Rdna) Asundexian Mometasone More therapies…

    Learn about Your Condition

    Systemic candida Cardiovascular disorder Actinic keratosis Circulatory collapse Femur fracture Exfoliation glaucoma Epileptic encephalopathy C3 glomerulopathy Anorexia nervosa Infection Post procedural infection Emphysema Trigeminal neuralgia Deep vein thrombosis Febrile neutropenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac ventricular thrombosis

  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac ventricular thrombosis
    • Acute myocardial infarction
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Perflutren
    • Apixaban
    Denmark Sweden
  • Study on Rivaroxaban, Dabigatran Etexilate, and Fluindione for Patients with Intra-Cardiac Thrombus

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Fluindione
    • Apixaban
    France
  • Study on Dabigatran and Phenprocoumon for Treating Left Ventricular Thrombosis After Heart Attack in Patients with STEMI

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac ventricular thrombosis
    • Acute myocardial infarction
    Investigated Drugs:
    • Clopidogrel
    • Dabigatran Etexilate
    • Phenprocoumon
    Austria

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!